Prot #M14-033: A Double-Blind, Randomized, Multicenter Study of Higher Versus Standard Adalimumab Dosing Regimens for Induction and Maintenance Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis

Project: Research project

Project Details

StatusActive
Effective start/end date12/23/1412/23/21

Funding

  • INC Research, LLC (Prot #M14-033)
  • AbbVie Inc. (Prot #M14-033)